DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3994, doi. 10.1038/onc.2014.334
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 30
Results: 15
1
2
Oncogenic Ras inhibits IRF1 to promote viral oncolysis.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3985, doi. 10.1038/onc.2014.331
- By:
- Publication type:
- Article
3
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 4018, doi. 10.1038/onc.2015.201
- By:
- Publication type:
- Article
4
Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3908, doi. 10.1038/onc.2014.321
- By:
- Publication type:
- Article
5
TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3946, doi. 10.1038/onc.2014.325
- By:
- Publication type:
- Article
6
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3957, doi. 10.1038/onc.2014.327
- By:
- Publication type:
- Article
7
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3968, doi. 10.1038/onc.2014.328
- By:
- Publication type:
- Article
8
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 4005, doi. 10.1038/onc.2014.316
- By:
- Publication type:
- Article
9
Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3926, doi. 10.1038/onc.2014.313
- By:
- Publication type:
- Article
10
CLIP2 as radiation biomarker in papillary thyroid carcinoma.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3917, doi. 10.1038/onc.2014.311
- By:
- Publication type:
- Article
11
Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3935, doi. 10.1038/onc.2014.324
- By:
- Publication type:
- Article
12
Genetic alterations of protein tyrosine phosphatases in human cancers.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3885, doi. 10.1038/onc.2014.326
- By:
- Publication type:
- Article
13
Transcriptional repression of Sin3B by Bmi-1 prevents cellular senescence and is relieved by oncogene activation.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 4011, doi. 10.1038/onc.2014.322
- By:
- Publication type:
- Article
14
miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3977, doi. 10.1038/onc.2014.329
- By:
- Publication type:
- Article
15
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
- Published in:
- Oncogene, 2015, v. 34, n. 30, p. 3895, doi. 10.1038/onc.2014.430
- By:
- Publication type:
- Article